NeuroBo Pharmaceuticals, Inc.
Methods of reducing risk of cardiovascular disease

Last updated:

Abstract:

Methods of lowering the plasma LDL-C levels in a patient on a stable dose of statin where the patient has an LDL-C level above treatment goal. Methods of decreasing a patient's risk for developing coronary heart disease, having a recurrent cardiovascular event or reducing the severity of a secondary cardiovascular event, wherein the patient is on a stable dose of statin and the patient has an LDL-C level above treatment goal.

Status:
Grant
Type:

Utility

Filling date:

29 Jun 2018

Issue date:

14 Jul 2020